annual interest expense:
$817.94M-$84.19M(-9.33%)Summary
- As of today (May 21, 2025), GSK annual interest expense is $817.94 million, with the most recent change of -$84.19 million (-9.33%) on December 31, 2024.
- During the last 3 years, GSK annual interest expense has fallen by -$233.12 million (-22.18%).
- GSK annual interest expense is now -47.53% below its all-time high of $1.56 billion, reached on December 31, 2008.
Performance
GSK Interest expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly interest expense:
$203.98M+$19.61M(+10.64%)Summary
- As of today (May 21, 2025), GSK quarterly interest expense is $203.98 million, with the most recent change of +$19.61 million (+10.64%) on March 31, 2025.
- Over the past year, GSK quarterly interest expense has dropped by -$6.57 million (-3.12%).
- GSK quarterly interest expense is now -51.66% below its all-time high of $421.97 million, reached on June 30, 2008.
Performance
GSK quarterly interest expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM interest expense:
$810.87M-$6.57M(-0.80%)Summary
- As of today (May 21, 2025), GSK TTM interest expense is $810.87 million, with the most recent change of -$6.57 million (-0.80%) on March 31, 2025.
- Over the past year, GSK TTM interest expense has dropped by -$54.20 million (-6.27%).
- GSK TTM interest expense is now -47.60% below its all-time high of $1.55 billion, reached on December 31, 2008.
Performance
GSK TTM interest expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Interest expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
GSK Interest expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -9.3% | -3.1% | -6.3% |
| 3 y3 years | -22.2% | -25.8% | -23.0% |
| 5 y5 years | -27.1% | -30.5% | -27.8% |
GSK Interest expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -22.2% | at low | -25.8% | +10.6% | -23.0% | at low |
| 5 y | 5-year | -27.1% | at low | -30.5% | +10.6% | -27.8% | at low |
| alltime | all time | -47.5% | +8013.4% | -51.7% | +598.5% | -47.6% | +1074.5% |
GSK Interest expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $203.98M(+10.6%) | $810.87M(-0.8%) |
| Dec 2024 | $817.94M(-9.3%) | $184.37M(-9.2%) | $817.44M(-1.0%) |
| Sep 2024 | - | $202.99M(-7.5%) | $825.58M(-3.2%) |
| Jun 2024 | - | $219.53M(+4.3%) | $853.05M(-1.4%) |
| Mar 2024 | - | $210.55M(+9.4%) | $865.08M(-4.0%) |
| Dec 2023 | $902.13M(-11.8%) | $192.51M(-16.5%) | $901.27M(-6.5%) |
| Sep 2023 | - | $230.46M(-0.5%) | $963.93M(-0.5%) |
| Jun 2023 | - | $231.56M(-6.2%) | $968.86M(-2.5%) |
| Mar 2023 | - | $246.75M(-3.3%) | $993.76M(-2.8%) |
| Dec 2022 | $1.02B(-2.7%) | $255.17M(+8.4%) | $1.02B(+1.0%) |
| Sep 2022 | - | $235.38M(-8.2%) | $1.01B(-3.2%) |
| Jun 2022 | - | $256.46M(-6.8%) | $1.05B(-0.7%) |
| Mar 2022 | - | $275.04M(+12.1%) | $1.05B(-0.2%) |
| Dec 2021 | $1.05B(-3.3%) | $245.34M(-8.7%) | $1.06B(-1.0%) |
| Sep 2021 | - | $268.86M(+1.8%) | $1.07B(+1.2%) |
| Jun 2021 | - | $264.18M(-4.7%) | $1.05B(-1.8%) |
| Mar 2021 | - | $277.08M(+8.2%) | $1.07B(-1.5%) |
| Dec 2020 | $1.09B(-3.1%) | $255.97M(+0.0%) | $1.09B(+3.1%) |
| Sep 2020 | - | $255.86M(-9.9%) | $1.06B(-4.2%) |
| Jun 2020 | - | $283.98M(-3.2%) | $1.10B(-1.8%) |
| Mar 2020 | - | $293.52M(+31.7%) | $1.12B(+0.2%) |
| Dec 2019 | $1.12B(+21.2%) | $222.87M(-26.2%) | $1.12B(+8.5%) |
| Sep 2019 | - | $301.88M(-0.9%) | $1.03B(-0.2%) |
| Jun 2019 | - | $304.59M(+4.4%) | $1.04B(+4.0%) |
| Mar 2019 | - | $291.81M(+116.0%) | $994.78M(+7.2%) |
| Dec 2018 | $925.97M(-2.7%) | $135.09M(-55.5%) | $928.23M(-7.3%) |
| Sep 2018 | - | $303.51M(+14.8%) | $1.00B(+5.2%) |
| Jun 2018 | - | $264.37M(+17.4%) | $952.06M(+2.0%) |
| Mar 2018 | - | $225.26M(+8.0%) | $933.14M(-1.6%) |
| Dec 2017 | $951.59M(-2.0%) | $208.48M(-17.9%) | $948.15M(-0.8%) |
| Sep 2017 | - | $253.95M(+3.5%) | $955.80M(+2.0%) |
| Jun 2017 | - | $245.44M(+2.1%) | $936.97M(-1.8%) |
| Mar 2017 | - | $240.28M(+11.2%) | $954.40M(-1.9%) |
| Dec 2016 | $971.46M(-13.5%) | $216.14M(-8.1%) | $973.23M(-5.1%) |
| Sep 2016 | - | $235.12M(-10.6%) | $1.03B(-3.1%) |
| Jun 2016 | - | $262.87M(+1.5%) | $1.06B(-3.1%) |
| Mar 2016 | - | $259.10M(-3.5%) | $1.09B(-2.7%) |
| Dec 2015 | $1.12B(-3.1%) | $268.48M(+0.2%) | $1.12B(+0.7%) |
| Sep 2015 | - | $268.07M(-9.8%) | $1.12B(-2.7%) |
| Jun 2015 | - | $297.16M(+2.6%) | $1.15B(-0.1%) |
| Mar 2015 | - | $289.51M(+10.9%) | $1.15B(-1.0%) |
| Dec 2014 | $1.16B(+0.1%) | $261.03M(-12.7%) | $1.16B(+1.7%) |
| Sep 2014 | - | $298.85M(+0.3%) | $1.14B(+0.2%) |
| Jun 2014 | - | $297.87M(-1.1%) | $1.14B(-0.4%) |
| Mar 2014 | - | $301.13M(+24.9%) | $1.14B(-1.2%) |
| Dec 2013 | $1.16B(-3.9%) | $241.18M(-18.6%) | $1.16B(-3.5%) |
| Sep 2013 | - | $296.17M(-2.1%) | $1.20B(-1.2%) |
| Jun 2013 | - | $302.59M(-4.0%) | $1.21B(+0.0%) |
| Mar 2013 | - | $315.33M(+11.6%) | $1.21B(+0.6%) |
| Dec 2012 | $1.20B | $282.54M(-9.2%) | $1.20B(+2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | $311.06M(+2.9%) | $1.17B(+0.3%) |
| Jun 2012 | - | $302.36M(-1.8%) | $1.17B(-3.5%) |
| Mar 2012 | - | $307.86M(+21.7%) | $1.21B(-0.1%) |
| Dec 2011 | $1.21B(+0.2%) | $252.99M(-17.7%) | $1.21B(-4.2%) |
| Sep 2011 | - | $307.54M(-10.7%) | $1.27B(+0.2%) |
| Jun 2011 | - | $344.23M(+11.3%) | $1.27B(+5.2%) |
| Mar 2011 | - | $309.17M(+0.9%) | $1.20B(-0.9%) |
| Dec 2010 | $1.21B(-1.3%) | $306.45M(+0.4%) | $1.21B(-3.3%) |
| Sep 2010 | - | $305.16M(+8.3%) | $1.25B(-1.7%) |
| Jun 2010 | - | $281.73M(-11.9%) | $1.28B(+1.7%) |
| Mar 2010 | - | $319.66M(-8.1%) | $1.26B(+2.3%) |
| Dec 2009 | $1.23B(-21.3%) | $347.93M(+6.6%) | $1.23B(-2.3%) |
| Sep 2009 | - | $326.41M(+25.1%) | $1.26B(-6.4%) |
| Jun 2009 | - | $261.00M(-10.5%) | $1.34B(-10.7%) |
| Mar 2009 | - | $291.75M(-22.6%) | $1.50B(-2.9%) |
| Dec 2008 | $1.56B(+403.6%) | $377.12M(-8.5%) | $1.55B(+32.2%) |
| Sep 2008 | - | $412.12M(-2.3%) | $1.17B(+54.4%) |
| Jun 2008 | - | $421.97M(+25.5%) | $758.14M(+31.5%) |
| Mar 2008 | - | $336.18M(+39.9%) | $576.46M(+34.7%) |
| Jun 2007 | - | $240.28M(+28.0%) | $427.93M(+128.0%) |
| Mar 2007 | - | $187.65M(+102.5%) | $187.65M(-46.5%) |
| Mar 2005 | - | $92.65M(-64.1%) | $351.01M(-13.9%) |
| Jun 2004 | - | $258.36M(+243.0%) | $407.73M(+173.0%) |
| Mar 2004 | - | $75.32M(+1.7%) | $149.37M(-35.8%) |
| Sep 2003 | - | $74.06M(-53.4%) | $232.84M(-26.0%) |
| Dec 2002 | $309.59M(-35.6%) | $158.79M(+144.0%) | $314.77M(+101.8%) |
| Sep 2002 | - | $65.07M(+53.4%) | $155.98M(+20.2%) |
| Jun 2002 | - | $42.41M(-12.5%) | $129.73M(+8.1%) |
| Mar 2002 | - | $48.50M(+24.9%) | $120.01M(-66.6%) |
| Sep 2001 | - | $38.83M(+18.8%) | $359.82M(-11.9%) |
| Jun 2001 | - | $32.68M(+11.9%) | $408.22M(-5.2%) |
| Mar 2001 | - | $29.20M(-88.7%) | $430.67M(-8.5%) |
| Dec 2000 | $480.48M(+44.1%) | $259.11M(+197.1%) | $470.51M(+122.6%) |
| Sep 2000 | - | $87.23M(+58.2%) | $211.40M(+70.2%) |
| Jun 2000 | - | $55.14M(-20.1%) | $124.18M(+79.9%) |
| Mar 2000 | - | $69.04M | $69.04M |
| Dec 1999 | $333.33M(-0.4%) | - | - |
| Dec 1998 | $334.80M(-10.0%) | - | - |
| Dec 1997 | $371.88M(-13.7%) | - | - |
| Dec 1996 | $431.08M(-19.0%) | - | - |
| Dec 1995 | $531.92M(+707.7%) | - | - |
| Jun 1994 | $65.85M(-27.7%) | - | - |
| Jun 1993 | $91.02M(-17.9%) | - | - |
| Jun 1992 | $110.82M(-20.4%) | - | - |
| Jun 1991 | $139.16M(+94.3%) | - | - |
| Jun 1990 | $71.60M(+60.5%) | - | - |
| Jun 1989 | $44.62M(+21.2%) | - | - |
| Jun 1988 | $36.82M(+119.5%) | - | - |
| Jun 1987 | $16.78M(+66.4%) | - | - |
| Jun 1986 | $10.08M | - | - |
FAQ
- What is GSK annual interest expense?
- What is the all time high annual interest expense for GSK?
- What is GSK annual interest expense year-on-year change?
- What is GSK quarterly interest expense?
- What is the all time high quarterly interest expense for GSK?
- What is GSK quarterly interest expense year-on-year change?
- What is GSK TTM interest expense?
- What is the all time high TTM interest expense for GSK?
- What is GSK TTM interest expense year-on-year change?
What is GSK annual interest expense?
The current annual interest expense of GSK is $817.94M
What is the all time high annual interest expense for GSK?
GSK all-time high annual interest expense is $1.56B
What is GSK annual interest expense year-on-year change?
Over the past year, GSK annual interest expense has changed by -$84.19M (-9.33%)
What is GSK quarterly interest expense?
The current quarterly interest expense of GSK is $203.98M
What is the all time high quarterly interest expense for GSK?
GSK all-time high quarterly interest expense is $421.97M
What is GSK quarterly interest expense year-on-year change?
Over the past year, GSK quarterly interest expense has changed by -$6.57M (-3.12%)
What is GSK TTM interest expense?
The current TTM interest expense of GSK is $810.87M
What is the all time high TTM interest expense for GSK?
GSK all-time high TTM interest expense is $1.55B
What is GSK TTM interest expense year-on-year change?
Over the past year, GSK TTM interest expense has changed by -$54.20M (-6.27%)